Blood Flow MRI for Monitoring Brain Tumors (Glioma)
This study is currently recruiting participants.
Verified February 2012 by Beth Israel Deaconess Medical Center
Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
Information provided by (Responsible Party):
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01538264
First received: February 20, 2012
Last updated: February 23, 2012
Last verified: February 2012
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | February 20, 2012 | ||||||||
| Last Updated Date | February 23, 2012 | ||||||||
| Start Date ICMJE | June 2006 | ||||||||
| Estimated Primary Completion Date | June 2012 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE | |||||||||
| Original Primary Outcome Measures ICMJE | |||||||||
| Change History | Complete list of historical versions of study NCT01538264 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | |||||||||
| Original Secondary Outcome Measures ICMJE | |||||||||
| Current Other Outcome Measures ICMJE | |||||||||
| Original Other Outcome Measures ICMJE | |||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Blood Flow MRI for Monitoring Brain Tumors | ||||||||
| Official Title ICMJE | Blood Flow MRI for Monitoring of Glioma Angiogenesis | ||||||||
| Brief Summary | The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner. |
||||||||
| Detailed Description | Our goals are:
|
||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Cross-Sectional |
||||||||
| Biospecimen | |||||||||
| Sampling Method | Non-Probability Sample | ||||||||
| Study Population | All subjects will be brain tumor patients recruited through the Brain Tumor Center at the Beth Israel Deaconess Medical Center. |
||||||||
| Condition ICMJE | Brain Tumors | ||||||||
| Intervention ICMJE | |||||||||
| Study Group/Cohort (s) | |||||||||
| Publications * | |||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Estimated Enrollment ICMJE | 125 | ||||||||
| Estimated Completion Date | October 2012 | ||||||||
| Estimated Primary Completion Date | June 2012 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
Subjects who have received nonstandard therapy may be excluded if the therapy might alter tumor blood flow or other imaging characteristic. |
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | United States | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT01538264 | ||||||||
| Other Study ID Numbers ICMJE | 2006-P-000116, R01CA115745-05 | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| Responsible Party | Beth Israel Deaconess Medical Center | ||||||||
| Study Sponsor ICMJE | Beth Israel Deaconess Medical Center | ||||||||
| Collaborators ICMJE | National Cancer Institute (NCI) | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | Beth Israel Deaconess Medical Center | ||||||||
| Verification Date | February 2012 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||
